Profusa, a digital health company specializing in continuous biochemical monitoring, received approval from the Nasdaq Hearings Panel to transfer its stock listing from The Nasdaq Global Market to The Nasdaq Capital Market. This move is conditional on Profusa meeting certain interim milestones and complying with bid price and stockholders' equity requirements by July 6, 2026. The company focuses on innovative biosensors and data platforms for personalized medical data. This transition aims to maintain its Nasdaq listing while it works on meeting financial standards.
Vishay Intertechnology introduced the VOLA617A, an automotive-grade phototransistor optocoupler designed for electric vehicles with up to 800V battery systems. It offers high isolation voltage ratings of 5000 V RMS and can handle DC voltages up to 10...
The global Climate Risk Management Market is projected to grow from $8.59 billion in 2026 to $19.08 billion by 2031, at a CAGR of 17.3%. Growth is fueled by increasing adoption of AI-driven analytics, geospatial intelligence, and cloud-native platfor...
Australia's social commerce market is projected to grow at a 10.6% annual rate, reaching $63.55 billion by 2026 and continuing to $93.38 billion by 2031. Growth is fueled by sectors like clothing, beauty, and electronics, with mobile commerce, video ...
TrendLife's ScamCheck app won the AI Safety Solution of the Year award for its innovative AI-powered scam detection. The app analyzes texts, calls, emails, and websites to identify subtle scam signs, including deepfake videos and multi-step fraud tac...
A webinar on June 30, 2026, hosted by the American Marketing Association and Notified, will discuss how brands can increase visibility in AI-powered search using press releases and earned media. The session will cover practical strategies to optimize...
